4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-14-000149
CIK 0001369786operating
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 3:33 PM ET
Size
4.5 KB
Accession
0001181431-14-000149
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Tax Payment
Common Stock
2013-02-22$16.85/sh−347$5,847→ 21,131 total
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 3:33 PM ET
- Size
- 4.5 KB